ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2022

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer.

Hirotaka Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.